CECCARANI, CAMILLA
CECCARANI, CAMILLA
Dipartimento di Scienze della Salute
Effect of docosahexaenoic acid as an anti-inflammatory for Caco-2 cells and modulating agent for gut microbiota in children with obesity (the DAMOCLE study)
2024 C. Lammi, E. Ottaviano, G. Fiore, C. Bollati, L. D'Adduzio, M. Fanzaga, C. Ceccarani, S. Vizzuso, G. Zuccotti, E. Borghi, E. Verduci
Gut microbiota profile in CDKL5 deficiency disorder patients
2024 E. Borghi, O. Xynomilakis, E. Ottaviano, C. Ceccarani, I. Viganò, P. Tognini, A. Vignoli
Curcumin Supplementation (Meriva®) Modulates Inflammation, Lipid Peroxidation and Gut Microbiota Composition in Chronic Kidney Disease
2022 F. Pivari, A. Mingione, G. Piazzini, C. Ceccarani, E. Ottaviano, C. Brasacchio, M. Dei Cas, M. Vischi, M.G. Cozzolino, P. Fogagnolo, A. Riva, G. Petrangolini, L. Barrea, L. Di Renzo, E. Borghi, P. Signorelli, R. Paroni, L. Soldati
Glycomacropeptide Safety and Its Effect on Gut Microbiota in Patients with Phenylketonuria: A Pilot Study
2022 C. Montanari, C. Ceccarani, A. Corsello, J. Zuvadelli, E. Ottaviano, M. Dei Cas, G. Banderali, G. Zuccotti, E. Borghi, E. Verduci
Insights into the role of the microbiota and of short-chain fatty acids in Rubinstein–Taybi syndrome
2021 E. Di Fede, E. Ottaviano, P. Grazioli, C. Ceccarani, A. Galeone, C. Parodi, E.A. Colombo, G. Bassanini, G. Fazio, M. Severgnini, D. Milani, E. Verduci, T. Vaccari, V. Massa, E. Borghi, C. Gervasini
EPILEPSY AND MICROBIOTA: TIME- AND DRUG-RELATED SHIFTS IN THE BACTERIAL COMMUNITY
2021 C. Ceccarani
Is Gut Microbiota a Key Player in Epilepsy Onset? A Longitudinal Study in Drug-Naive Children
2021 C. Ceccarani, I. Vigano, E. Ottaviano, M.G. Redaelli, M. Severgnini, A. Vignoli, E. Borghi
Interplay between genetic disorders and gut microbial community: Rubinstein-Taybi syndrome as a model
2020 G. Bassanini, E. Di Fede, E. Colombo, C. Ceccarani, E. Ottaviano, V. Massa, C. Gervasini, E. Borghi
Interplay between Genetic Disorders and Gut Microbial Community: Rubinstein-Taybi Syndrome as a Model
2020 G. Bassanini, E. Di Fede, E.A. Colombo, C. Ceccarani, E. Ottaviano, V. Massa, C. Gervasini, E. Borghi
Proteobacteria Overgrowth and Butyrate-Producing Taxa Depletion in the Gut Microbiota of Glycogen Storage Disease Type 1 Patients
2020 C. Ceccarani, G. Bassanini, C. Montanari, M.C. Casiraghi, E. Ottaviano, G. Morace, G. Biasucci, S. Paci, E. Borghi, E. Verduci
Antiepileptics influence gut microbiota: a possible relationship with drug-resistance?
2019 G. Bassanini, C. Ceccarani, I. Vigano', E. Ottaviano, M.G. Redaelli, M. Severgnini, A. Vignoli, E. Borghi
Microbial colonization during early phases of amphibian life
2019 G. Bassanini, F. Di Renzo, V. Massa, C. Ceccarani, P. Grazioli, R. Bacchetta, E. Ottaviano, E. Menegola, E. Borghi
Dietary treatment promotes gut microbial community changes in subjects affected by glycogenosis type 1
2019 G. Bassanini, C. Montanari, C. Ceccarani, E. Ottaviano, S. Paci, E. Verduci, E. Borghi
Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism
2019 M. Barichella, M. Severgnini, R. Cilia, E. Cassani, C. Bolliri, S. Caronni, V. Ferri, R. Cancello, C. Ceccarani, S. Faierman, G. Pinelli, G. De Bellis, L. Zecca, E. Cereda, C. Consolandi, G. Pezzoli
Phenylketonuria Diet Promotes Shifts in Firmicutes Populations
2019 G. Bassanini, C. Ceccarani, F. Borgo, M. Severgnini, V. Rovelli, G. Morace, E. Verduci, E. Borghi
Impact of the ketogenic diet on human gut
2018 E. Meroni, C. Ferraris, A. Tagliabue, E. Borghi, F. Borgo, G. Bassanini, C. Ceccarani, M.C. Casiraghi, D. Erba
Quality of dietary carbohydrates affects gut microbial community of phenylketonuric subjects
2018 F. Borgo, G. Bassanini, C. Ceccarani, M. Severgnini, M.C. Casiraghi, G. Morace, E. Verduci, E. Borghi
Milk microbiome diversity and bacterial group prevalence in a comparison between healthy Holstein Friesian and Rendena cows
2018 P. Cremonesi, C. Ceccarani, G. Curone, M. Severgnini, C. Pollera, V. Bronzo, F. Riva, M.F. Addis, J. Filipe, M. Amadori, E. Trevisi, D. Vigo, P. Moroni, B. Castiglioni